Brazil’s Pharma Regulator, Anvisa, Approves Medicinal Cannabis Products

Brazilian pharmaceutical regulator Anvisa on Tuesday approved regulations for the roll-out of medicinal cannabis-based products but in a separate vote blocked a proposal to allow domestic medical marijuana plantations.

Anvisa’s approval of rules to regulate the nascent medical marijuana market represents a major shift in a country that has suffered years of deadly drug violence.

Nonetheless, the decision to prohibit domestic plantations shows that Brazil, led by far-right President Jair Bolsonaro, is not yet willing to join peers Colombia and Uruguay and develop its own vertically integrated medical marijuana sector.

A spokesman for Anvisa said that Brazilian firms interested in manufacturing cannabis-based products would need to import inputs from aboard.

It its statement announcing the regulatory approval, Anvisa said the new rules would be published in the country’s official gazette in the next few days and come into law 90 days after that. Anvisa also set out specific rules for the manufacture, import, sale, packaging, marketing and regulation of the new class of cannabis-based products.

Read the full article at  https://www.reuters.com/article/us-brazil-marijuana/brazil-approves-medical-marijuana-rules-blocks-cannabis-cultivation-idUSKBN1Y726W

Primary Sponsor

 


Karma Koala Podcast

Top Marijuana Blog